GLP-1 medications can make a difference by supporting appetite control, stabilizing blood sugar, and helping your body respond more effectively to routine lifestyle changes
Both are semaglutide but their FDA-approved uses and recommended dosages differ Wegovy and Ozempic are both GLP-1 medications that include the drug semaglutide
There are also new formulations that act on other receptors in addition to GLP-1 receptors to significantly increase the medication's effectiveness , in some cases doubling the weight reduction patients experience
Youre going from a dual-receptor medication to a single-receptor one, and for many patients, that difference is noticeable
And while metformin has been the first-line therapy in treating type 2 diabetes, the FDA announced in 2019 that Rybelsus (semaglutide), a GLP-1, can also be offered as a first-line treatment
A NICE committee is due to meet in July 2026 to discuss NHS use in England and Wales